Melatonine Newbury

Melatonin, the active ingredient in Melatonine Newbury, is a melatonin receptor agonist presented as an oral formulation for oral use. It is used to help regulate the sleep‑wake cycle and to promote sleep onset in adults with insomnia or circadian rhythm disturbances.

GNH USA supplies Melatonine Newbury as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The firm adheres to stringent quality standards and offers reliable sourcing for regulated markets across Europe and other regions and beyond.

Melatonin acts on the melatonin receptor pathway to address sleep‑related disorders.

- Insomnia: improves sleep onset and maintenance in adults who have difficulty falling or staying asleep. - Sleep‑wake rhythm disorders: helps synchronize circadian rhythm in conditions such as shift‑work disorder. - Delayed sleep phase syndrome: facilitates earlier sleep onset by advancing the internal clock.

Melatonin is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Drowsiness - Headache - Dizziness - Nausea

Serious or Rare Side Effects: - Allergic skin reactions (rash, itching, swelling) - Mood changes such as depression or agitation

When considering melatonin, several safety measures should be observed.

- Dosage adjustment: tailor the dose to individual response and age. - Medical conditions: assess for underlying sleep disorders, depression, or seizure disorders. - Concurrent medications: review all current drugs for potential interactions. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Melatonin may interact with other medicines, requiring attention to avoid reduced efficacy or increased risk.

Major Interactions (Avoid): - Anticoagulants: melatonin may enhance anticoagulant effect, increasing bleeding risk. - Immunosuppressants: melatonin could diminish immunosuppressive activity, potentially leading to organ rejection.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, antihistamines): additive sedative effect may cause excessive drowsiness. - Oral contraceptives: melatonin may reduce contraceptive effectiveness. - Antidiabetic agents: melatonin can affect glucose metabolism, requiring blood sugar monitoring.